TY - JOUR
T1 - Use of a melody pulmonary valve in transcatheter valve-in-valve replacement for tricuspid valve bioprosthesis degeneration
AU - Filsoof, David M.
AU - Snipelisky, David F.
AU - Shapiro, Brian P.
N1 - Publisher Copyright:
© 2014 by the Texas Heart ® Institute, Houston.
Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 2014/9/1
Y1 - 2014/9/1
N2 - Bioprosthetic heart valves can degenerate and fail over time. Repeat surgery as a means of replacement increases morbidity and mortality rates, and some patients are not candidates for reoperation. A newer treatment, percutaneous transcatheter valve-in-valve implantation, might delay or substitute for invasive procedures. We present the case of a 51-year-old woman, a poor candidate for surgery who had prosthetic tricuspid valve degeneration and stenosis. We successfully performed valve-in-valve placement of a Melody® valve, using a procedure originally intended to treat pulmonary valve conduit obstruction or regurgitation. To our knowledge, this is among the first case reports to describe the use of the Melody pulmonary valve in transcatheter valve-in-valve replacement for prosthetic tricuspid stenosis that was otherwise not correctable. Additional data and longer follow-up periods are necessary to gain an understanding of ideal indications and selection of patients for the percutaneous transcatheter treatment of tricuspid valve stenosis.
AB - Bioprosthetic heart valves can degenerate and fail over time. Repeat surgery as a means of replacement increases morbidity and mortality rates, and some patients are not candidates for reoperation. A newer treatment, percutaneous transcatheter valve-in-valve implantation, might delay or substitute for invasive procedures. We present the case of a 51-year-old woman, a poor candidate for surgery who had prosthetic tricuspid valve degeneration and stenosis. We successfully performed valve-in-valve placement of a Melody® valve, using a procedure originally intended to treat pulmonary valve conduit obstruction or regurgitation. To our knowledge, this is among the first case reports to describe the use of the Melody pulmonary valve in transcatheter valve-in-valve replacement for prosthetic tricuspid stenosis that was otherwise not correctable. Additional data and longer follow-up periods are necessary to gain an understanding of ideal indications and selection of patients for the percutaneous transcatheter treatment of tricuspid valve stenosis.
KW - Heart valve diseases/pathology
KW - Heart valve prosthesis implantation/instrumentation/methods/trends
KW - Minimally invasive/methods
KW - Surgical procedures
KW - Treatment outcome
KW - Tricuspid valve insufficiency
KW - Tricuspid valve stenosis/ therapy
UR - http://www.scopus.com/inward/record.url?scp=84908111212&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908111212&partnerID=8YFLogxK
U2 - 10.14503/THIJ-13-3544
DO - 10.14503/THIJ-13-3544
M3 - Article
C2 - 25425984
AN - SCOPUS:84908111212
VL - 41
SP - 511
EP - 513
JO - Texas Heart Institute Journal
JF - Texas Heart Institute Journal
SN - 0730-2347
IS - 5
ER -